111, Inc.(YI)Earnings, Financials & Key Ratios
YI•NASDAQ
$5.58
$48M mkt cap·Price updated May 7, 2026
About111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.Show more
- Revenue$14.4B-3.7%
- EBITDA$19M+105.8%
- Net Income-$65M+83.5%
- EPS (Diluted)-7.52+83.9%
- Gross Margin5.76%+91.9%
- EBITDA Margin0.13%+106.0%
- Operating Margin0.01%+100.6%
- Net Margin-0.45%+82.9%
- ROE-19.71%+76.8%
- ROIC1.09%+100.9%
- Debt/Equity0.67-58.0%
- Interest Coverage0.07+100.4%
YI Key Insights
111, Inc. (YI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 7/9
- ✓Strong 5Y sales CAGR of 29.5%
- ✓Trading at only 0.9x book value
- ✓Efficient asset utilization: 5.2x turnover
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
YI Price & Volume
111, Inc. (YI) stock price & volume — 10-year historical chart
Loading chart...
YI Growth Metrics
111, Inc. (YI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years29.51%
3 Years5.04%
TTM-3.69%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM77.63%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM78.07%
Return on Capital
10 Years-41.99%
5 Years-40.14%
3 Years-35.2%
Last Year0.54%
YI Peer Comparison
111, Inc. (YI) competitors in Digital Health and Online Pharmacy — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 6.63B | 25.67 | 50.32 | 59% | 5.47% | 23.73% | 2.07 | |
 TDOC | 1.26B | 6.96 | -6.11 | -1.54% | -6.81% | -12.37% | 0.75 | |
 PINC | 2.34B | 28.26 | 128.45 | -10.86% | -2.42% | -1.59% | 0.18 | |
 CRON | 980.69M | 2.57 | 64.4% | -4.89% | -0.86% | 0.00 | ||
 OPRX | 123.59M | 6.63 | 24.56 | 18.78% | 4.69% | 4.22% | 0.04 | |
 MCK | 92.15B | 752.30 | 29.25 | 16.22% | 1.18% | 301.44% | ||
 CAH | 43.59B | 185.22 | 28.72 | -1.87% | 0.62% | |||
 CSGP | 14.83B | 34.98 | 2107.23 | 18.67% | 0.74% | 0.3% | 0.14 |
Compare YI vs Peers
111, Inc. (YI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
YI Income Statement
111, Inc. (YI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 873.84M | 959.49M | 1.79B | 3.95B | 8.2B | 12.43B | 13.52B | 14.95B | 14.4B | 14.18B |
| Revenue Growth % | - | 9.8% | 86.14% | 121.28% | 107.57% | 51.48% | 8.78% | 10.59% | -3.66% | -3.69% |
| Cost of Goods Sold | 796.23M | 868.72M | 1.68B | 3.79B | 7.84B | 11.8B | 12.68B | 14.5B | 13.57B | 13.48B |
| COGS % of Revenue | 91.12% | 90.54% | 94.16% | 95.82% | 95.54% | 95% | 93.79% | 97% | 94.24% | - |
| Gross Profit | 77.61M▲ 0% | 90.77M▲ 17.0% | 104.27M▲ 14.9% | 165.18M▲ 58.4% | 365.83M▲ 121.5% | 621.1M▲ 69.8% | 839.98M▲ 35.2% | 448.44M▼ 46.6% | 829.23M▲ 84.9% | 703.37M▲ 0% |
| Gross Margin % | 8.88% | 9.46% | 5.84% | 4.18% | 4.46% | 5% | 6.21% | 3% | 5.76% | 4.96% |
| Gross Profit Growth % | - | 16.96% | 14.88% | 58.42% | 121.47% | 69.78% | 35.24% | -46.61% | 84.91% | - |
| Operating Expenses | 441.89M | 344.79M | 504.64M | 658.7M | 839.14M | 1.26B | 1.21B | 798.54M | 827.12M | 708.08M |
| OpEx % of Revenue | 50.57% | 35.93% | 28.26% | 16.67% | 10.23% | 10.17% | 8.96% | 5.34% | 5.74% | - |
| Selling, General & Admin | 443.88M | 347.52M | 503.98M | 654.96M | 527.84M | 720.13M | 663.5M | 672.59M | 384.8M | 357.47M |
| SG&A % of Revenue | 50.8% | 36.22% | 28.22% | 16.57% | 6.43% | 5.8% | 4.91% | 4.5% | 2.67% | - |
| Research & Development | 61.77M | 48.13M | 71.25M | 61.9M | 92.08M | 189.28M | 139.5M | 0 | 0 | 14.87M |
| R&D % of Revenue | 7.07% | 5.02% | 3.99% | 1.57% | 1.12% | 1.52% | 1.03% | - | - | - |
| Other Operating Expenses | -3.35M | 4.23M | 11.53M | -58.17M | 219.23M | 353.82M | 407.97M | 125.95M | 442.31M | 2M |
| Operating Income | -364.28M▲ 0% | -254.02M▲ 30.3% | -400.38M▼ 57.6% | -493.51M▼ 23.3% | -473.31M▲ 4.1% | -642.14M▼ 35.7% | -371M▲ 42.2% | -350.1M▲ 5.6% | 2.11M▲ 100.6% | -4.71M▲ 0% |
| Operating Margin % | -41.69% | -26.47% | -22.42% | -12.49% | -5.77% | -5.17% | -2.74% | -2.34% | 0.01% | -0.03% |
| Operating Income Growth % | - | 30.27% | -57.61% | -23.26% | 4.09% | -35.67% | 42.22% | 5.63% | 100.6% | - |
| EBITDA | -352.22M | -239.2M | -389.11M | -481.85M | -459.29M | -614.92M | -330.18M | -328.32M | 19.08M | 10.52M |
| EBITDA Margin % | -40.31% | -24.93% | -21.79% | -12.19% | -5.6% | -4.95% | -2.44% | -2.2% | 0.13% | 0.07% |
| EBITDA Growth % | - | 32.09% | -62.67% | -23.83% | 4.68% | -33.88% | 46.3% | 0.56% | 105.81% | 104.15% |
| D&A (Non-Cash Add-back) | 12.06M | 14.82M | 11.27M | 11.67M | 14.02M | 27.22M | 40.82M | 21.78M | 16.97M | 13.93M |
| EBIT | -362.69M | -249.27M | -400.38M | -498.2M | -473.31M | -615.54M | -362.63M | -333.04M | 7.65M | -1.39M |
| Net Interest Income | 1.56M | 3.96M | 4.35M | 1.18M | -2.5M | 4.29M | -5.33M | -11.31M | -21.29M | -24.99M |
| Interest Income | 2.31M | 4.01M | 4.35M | 4.8M | 6.31M | 9.78M | 8.12M | 8.83M | 7.04M | 4.39M |
| Interest Expense | 751K | 55K | 0 | 3.62M | 8.82M | 5.49M | 13.44M | 20.14M | 28.33M | 29.25M |
| Other Income/Expense | 834K | 4.7M | 18.34M | -8.31M | 6.2M | 21.11M | -5.07M | -3.08M | -22.79M | -25.85M |
| Pretax Income | -363.45M▲ 0% | -249.33M▲ 31.4% | -382.03M▼ 53.2% | -501.83M▼ 31.4% | -467.11M▲ 6.9% | -621.02M▼ 33.0% | -376.07M▲ 39.4% | -353.18M▲ 6.1% | -20.68M▲ 94.1% | -30.56M▲ 0% |
| Pretax Margin % | -41.59% | -25.99% | -21.39% | -12.7% | -5.69% | -5% | -2.78% | -2.36% | -0.14% | -0.22% |
| Income Tax | -3.37M | 0 | 8K | 0 | 0 | 0 | 0 | 251K | 96K | 27K |
| Effective Tax Rate % | 0.93% | 0% | -0% | 0% | 0% | 0% | 0% | -0.07% | -0.46% | -0.09% |
| Net Income | -362.68M▲ 0% | -248.58M▲ 31.5% | -380.09M▼ 52.9% | -501.83M▼ 32.0% | -456.53M▲ 9.0% | -669.81M▼ 46.7% | -416.88M▲ 37.8% | -392.69M▲ 5.8% | -64.74M▲ 83.5% | -74.15M▲ 0% |
| Net Margin % | -41.5% | -25.91% | -21.28% | -12.7% | -5.57% | -5.39% | -3.08% | -2.63% | -0.45% | -0.52% |
| Net Income Growth % | - | 31.46% | -52.9% | -32.03% | 9.03% | -46.72% | 37.76% | 5.8% | 83.51% | 77.63% |
| Net Income (Continuing) | -363.45M | -249.33M | -382.04M | -501.83M | -467.11M | -621.02M | -376.07M | -353.43M | -20.78M | -30.59M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 2.19M | 1.44M | -512K | -2.73M | 973.24M | 1.02B | 1.06B | 859.55M | 1.02B | 995.97M |
| EPS (Diluted) | -100.74▲ 0% | -69.04▲ 31.5% | -76.44▼ 10.7% | -60.16▲ 21.3% | -55.40▲ 7.9% | -80.76▼ 45.8% | -50.04▲ 38.0% | -46.58▲ 6.9% | -7.52▲ 83.9% | -8.54▲ 0% |
| EPS Growth % | - | 31.47% | -10.72% | 21.3% | 7.91% | -45.78% | 38.04% | 6.91% | 83.86% | 78.07% |
| EPS (Basic) | -116.10 | -69.04 | -76.44 | -60.16 | -55.40 | -80.76 | -50.04 | -46.58 | -7.52 | - |
| Diluted Shares Outstanding | 3.6M | 3.6M | 4.97M | 8.18M | 8.24M | 8.29M | 8.33M | 8.43M | 8.62M | 8.68M |
| Basic Shares Outstanding | 3.12M | 3.6M | 4.97M | 8.18M | 8.24M | 8.29M | 8.33M | 8.43M | 8.62M | 8.68M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
YI Balance Sheet
111, Inc. (YI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 900.81M | 730.47M | 1.51B | 1.48B | 2.87B | 2.8B | 3.24B | 2.93B | 2.65B | 2.37B |
| Cash & Short-Term Investments | 640.33M | 461.19M | 1.11B | 613.75M | 1.49B | 843.95M | 879.53M | 653.67M | 462.29M | 447.47M |
| Cash Only | 373.5M | 167.66M | 853.74M | 613.75M | 1.19B | 661.39M | 673.67M | 603.52M | 462.29M | 447.47M |
| Short-Term Investments | 266.82M | 293.53M | 252.81M | 0 | 300.17M | 182.56M | 205.86M | 50.14M | 0 | 0 |
| Accounts Receivable | 28.39M | 20.4M | 87.4M | 88.83M | 175.68M | 495.2M | 600.49M | 647.48M | 630.72M | 343.11M |
| Days Sales Outstanding | 11.86 | 7.76 | 17.86 | 8.2 | 7.82 | 14.55 | 16.22 | 15.81 | 15.99 | 11.85 |
| Inventory | 134.73M | 144.06M | 210.84M | 486.27M | 766.53M | 1.12B | 1.5B | 1.42B | 1.39B | 1.28B |
| Days Inventory Outstanding | 61.76 | 60.53 | 45.76 | 46.87 | 35.7 | 34.66 | 43.16 | 35.73 | 37.31 | 37.51 |
| Other Current Assets | 97.36M | 102.93M | 156.11M | 285.33M | 432.59M | 332M | 250.25M | 206.88M | 62.82M | 297.43M |
| Total Non-Current Assets | 40.8M | 32.92M | 39.32M | 128.86M | 153.78M | 344.1M | 237.99M | 155.71M | 138.09M | 110.24M |
| Property, Plant & Equipment | 24.49M | 17.03M | 20.3M | 117.69M | 142.07M | 314.1M | 212.37M | 138.14M | 121.97M | 97.46M |
| Fixed Asset Turnover | 35.68x | 56.35x | 87.97x | 33.58x | 57.74x | 39.56x | 63.65x | 108.21x | 118.07x | 125.74x |
| Goodwill | 0 | 0 | 0 | 0 | 5.6M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 5.31M | 4.75M | 4.5M | 8.02M | 920K | 4.91M | 3.27M | 2.26M | 1.44M | 1.12M |
| Long-Term Investments | 11M | 11.14M | 11.14M | 140K | 140K | 3M | 2M | 2M | 0 | 1M |
| Other Non-Current Assets | 0 | 0 | 3.38M | 3.01M | 5.06M | 22.09M | 20.35M | 13.31M | 14.68M | 56.17M |
| Total Assets | 941.61M▲ 0% | 763.38M▼ 18.9% | 1.55B▲ 102.6% | 1.61B▲ 4.1% | 3.03B▲ 87.9% | 3.15B▲ 3.9% | 3.47B▲ 10.4% | 3.09B▼ 11.1% | 2.79B▼ 9.8% | 2.48B▲ 0% |
| Asset Turnover | 0.93x | 1.26x | 1.15x | 2.45x | 2.71x | 3.95x | 3.89x | 4.84x | 5.17x | 5.20x |
| Asset Growth % | - | -18.93% | 102.57% | 4.13% | 87.95% | 3.94% | 10.43% | -11.08% | -9.75% | -41.65% |
| Total Current Liabilities | 172.15M | 201.16M | 314.52M | 745.63M | 1.63B | 2.13B | 2.73B | 2.75B | 2.34B | 2.1B |
| Accounts Payable | 97.98M | 128.14M | 212.26M | 444.33M | 1.07B | 1.35B | 1.76B | 1.59B | 1.72B | 1.55B |
| Days Payables Outstanding | 44.92 | 53.84 | 46.07 | 42.83 | 49.99 | 41.66 | 50.82 | 39.99 | 46.3 | 46.49 |
| Short-Term Debt | 0 | 0 | 0 | 95.08M | 229.25M | 259.66M | 178.99M | 338.07M | 160.98M | 170M |
| Deferred Revenue (Current) | 12.96M | 18.02M | 21.5M | 74.77M | 131.01M | 202.56M | 323.57M | 193.46M | 185.87M | 185.87M |
| Other Current Liabilities | 32.32M | 37.66M | 50.68M | -7.12M | 67.03M | 69.29M | 190.54M | 504.16M | 90.5M | 0 |
| Current Ratio | 5.23x | 3.63x | 4.79x | 1.99x | 1.76x | 1.32x | 1.19x | 1.07x | 1.13x | 1.13x |
| Quick Ratio | 4.45x | 2.92x | 4.12x | 1.33x | 1.29x | 0.79x | 0.64x | 0.55x | 0.54x | 0.54x |
| Cash Conversion Cycle | 28.7 | 14.45 | 17.55 | 12.25 | -6.47 | 7.55 | 8.56 | 11.55 | 7 | 2.86 |
| Total Non-Current Liabilities | 193.93M | 243.41M | 8.13M | 90.74M | 66.12M | 167.15M | 100.47M | 67.87M | 64.41M | 51.6M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 57.01M | 62.39M | 165.61M | 100.47M | 62.62M | 55.45M | 209.04M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 193.93M | 243.41M | 8.13M | 5.94M | 3.74M | 1.54M | 0 | 5.25M | 8.96M | 34.6M |
| Total Liabilities | 366.08M | 444.56M | 322.65M | 836.37M | 1.7B | 2.3B | 2.83B | 2.81B | 2.41B | 2.15B |
| Total Debt | 0 | 0 | 0 | 208.76M | 329.35M | 491.01M | 344.19M | 443.23M | 256.77M | 212.93M |
| Net Debt | -373.5M | -167.66M | -853.74M | -461.65M | -860.27M | -170.38M | -329.48M | -160.29M | -205.52M | -234.55M |
| Debt / Equity | - | - | - | 0.27x | 0.25x | 0.58x | 0.53x | 1.61x | 0.67x | 0.67x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | 13.46x | 20.25x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | -10.77x | -10.77x |
| Interest Coverage | -485.06x | -4618.58x | - | -136.25x | -53.68x | -117.01x | -27.60x | -17.38x | 0.07x | -0.05x |
| Total Equity | 575.52M▲ 0% | 318.82M▼ 44.6% | 1.22B▲ 283.8% | 773.92M▼ 36.8% | 1.33B▲ 71.9% | 848.71M▼ 36.2% | 648.24M▼ 23.6% | 276.1M▼ 57.4% | 380.76M▲ 37.9% | 322.9M▲ 0% |
| Equity Growth % | - | -44.6% | 283.84% | -36.76% | 71.94% | -36.22% | -23.62% | -57.41% | 37.91% | 101.59% |
| Book Value per Share | 159.87 | 88.56 | 246.10 | 94.57 | 161.50 | 102.34 | 77.80 | 32.75 | 44.19 | 37.21 |
| Total Shareholders' Equity | 573.34M | 317.38M | 1.22B | 776.66M | 357.4M | -173.32M | -414.6M | -583.45M | -642.64M | -673.07M |
| Common Stock | 25K | 25K | 54K | 55K | 55K | 56K | 56K | 57K | 58K | 58K |
| Retained Earnings | -755.06M | -1B | -1.38B | -1.88B | -2.34B | -3.01B | -3.43B | -3.82B | -3.88B | -3.92B |
| Treasury Stock | 0 | 0 | 0 | -22.99M | -34.97M | -40.86M | -40.86M | -5.89M | -5.89M | -5.89M |
| Accumulated OCI | 64.87M | 47.55M | 67.07M | 76.44M | 62.91M | 59.37M | 75.59M | 72.51M | 74.36M | 73.42M |
| Minority Interest | 2.19M | 1.44M | -512K | -2.73M | 973.24M | 1.02B | 1.06B | 859.55M | 1.02B | 995.97M |
YI Cash Flow Statement
111, Inc. (YI) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -388.65M | -204.37M | -343.02M | -510.19M | -116.78M | -688.84M | -23.15M | -447.24M | 263.02M | 263.02M |
| Operating CF Margin % | -44.48% | -21.3% | -19.21% | -12.91% | -1.42% | -5.54% | -0.17% | -2.99% | 1.83% | - |
| Operating CF Growth % | - | 47.41% | -67.84% | -48.74% | 77.11% | -489.87% | 96.64% | -1831.77% | 158.81% | 125.39% |
| Net Income | -363.45M | -249.33M | -382.04M | -501.83M | -456.53M | -621.02M | -376.07M | -353.43M | -20.78M | -74.15M |
| Depreciation & Amortization | 12.06M | 14.82M | 11.27M | 11.67M | 14.02M | 27.22M | 40.82M | 21.78M | 16.97M | 16.97M |
| Stock-Based Compensation | 3.44M | 9.92M | 51.36M | 54.28M | 75.69M | 145.59M | 162.07M | 226.69M | 20.15M | 7M |
| Deferred Taxes | 0 | 0 | 1.95M | 3.55M | -89.71M | 86.36M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 22K | -10K | -11.71M | 25.39M | 334.79M | 42.88M | 105.56M | 82.05M | 54.01M | 86.59M |
| Working Capital Changes | -40.72M | 20.22M | -13.84M | -103.26M | 4.97M | -369.87M | 44.46M | -424.33M | 192.66M | 59.93M |
| Change in Receivables | 1.98M | 7.99M | -8.17M | -36.68M | -98.28M | -242.4M | -86.98M | -49.9M | 121.97M | 123.2M |
| Change in Inventory | -22.03M | -9.32M | -66.78M | -276.23M | 24.22M | -400.55M | -406.29M | 59.59M | 28.11M | 28.11M |
| Change in Payables | 8.94M | 30.16M | 84.12M | 232.08M | 629.02M | 274M | 417.5M | -176.74M | 132.73M | 0 |
| Cash from Investing | -267.55M | -36.13M | 44.45M | 237.53M | -324.67M | 60.14M | -47.17M | 151.74M | 37.38M | 86.05M |
| Capital Expenditures | -6.92M | -6.86M | -14.82M | -24.61M | -25.5M | -62.69M | -31.57M | -9.82M | -15.2M | 0 |
| CapEx % of Revenue | 0.79% | 0.71% | 0.83% | 0.62% | 0.31% | 0.5% | 0.23% | 0.07% | 0.11% | - |
| Acquisitions | 0 | 0 | 376K | 4.58M | 323.4M | 100K | -2.96M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.3M | -5K | -275K | -4.55M | -324.67M | 216K | -2.99M | 1.65M | 458K | 86.05M |
| Cash from Financing | 148.42M | 49.5M | 972.7M | 106.95M | 1.07B | 74.34M | 22.73M | 205.98M | -406.24M | -200.6M |
| Debt Issued (Net) | -47.5M | 0 | 0 | 95.08M | 134.17M | 30.41M | -80.67M | 169.51M | -177.09M | 0 |
| Equity Issued (Net) | 0 | 0 | 972.7M | -22.99M | -5.66M | -5.89M | 274K | 223K | 14K | -13.52M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -22.99M | -11.98M | -5.89M | 0 | 0 | 0 | -13.52M |
| Other Financing | 195.92M | 49.5M | 0 | 34.86M | 941.89M | 49.82M | 103.13M | 36.25M | -229.16M | -187.08M |
| Net Change in Cash | -472.45M▲ 0% | -205.84M▲ 56.4% | 686.08M▲ 433.3% | -156.02M▼ 122.7% | 620.81M▲ 497.9% | -557.86M▼ 189.9% | -43.88M▲ 92.1% | -93.24M▼ 112.5% | -105.22M▼ 12.8% | -2.43M▲ 0% |
| Free Cash Flow | -395.57M▲ 0% | -211.23M▲ 46.6% | -357.84M▼ 69.4% | -534.8M▼ 49.5% | -142.28M▲ 73.4% | -751.53M▼ 428.2% | -54.73M▲ 92.7% | -457.07M▼ 735.2% | 247.82M▲ 154.2% | 97.31M▲ 0% |
| FCF Margin % | -45.27% | -22.02% | -20.04% | -13.53% | -1.73% | -6.05% | -0.4% | -3.06% | 1.72% | 0.69% |
| FCF Growth % | - | 46.6% | -69.4% | -49.45% | 73.4% | -428.2% | 92.72% | -735.2% | 154.22% | 223.6% |
| FCF per Share | -109.88 | -58.68 | -71.96 | -65.35 | -17.27 | -90.62 | -6.57 | -54.22 | 28.76 | 28.76 |
| FCF Conversion (FCF/Net Income) | 1.07x | 0.82x | 0.90x | 1.02x | 0.26x | 1.03x | 0.06x | 1.14x | -4.06x | -1.31x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.42M | 6.16M | 0 |
| Taxes Paid | 0 | 0 | 8K | 0 | 0 | 0 | 0 | 251K | 96K | 0 |
YI Key Ratios
111, Inc. (YI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -55.59% | -49.28% | -50.24% | -43.38% | -61.47% | -55.7% | -84.97% | -19.71% | -21.35% |
| Return on Invested Capital (ROIC) | -107.89% | -115.23% | -100.18% | -84.59% | -83.85% | -55.81% | -120.84% | 1.09% | 1.09% |
| Gross Margin | 9.46% | 5.84% | 4.18% | 4.46% | 5% | 6.21% | 3% | 5.76% | 4.96% |
| Net Margin | -25.91% | -21.28% | -12.7% | -5.57% | -5.39% | -3.08% | -2.63% | -0.45% | -0.52% |
| Debt / Equity | - | - | 0.27x | 0.25x | 0.58x | 0.53x | 1.61x | 0.67x | 0.67x |
| Interest Coverage | -4618.58x | - | -136.25x | -53.68x | -117.01x | -27.60x | -17.38x | 0.07x | -0.05x |
| FCF Conversion | 0.82x | 0.90x | 1.02x | 0.26x | 1.03x | 0.06x | 1.14x | -4.06x | -1.31x |
| Revenue Growth | 9.8% | 86.14% | 121.28% | 107.57% | 51.48% | 8.78% | 10.59% | -3.66% | -3.69% |
YI Frequently Asked Questions
111, Inc. (YI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
111, Inc. (YI) reported $14.18B in revenue for fiscal year 2024. This represents a 1523% increase from $873.8M in 2016.
111, Inc. (YI) saw revenue decline by 3.7% over the past year.
111, Inc. (YI) reported a net loss of $74.1M for fiscal year 2024.
Dividend & Returns
111, Inc. (YI) has a return on equity (ROE) of -19.7%. Negative ROE indicates the company is unprofitable.
111, Inc. (YI) generated $97.3M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More YI
111, Inc. (YI) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates